Development of resistance to mopc-315 plasmacytoma after intralesional and intraperitoneal melphalan therapy of tumor-bearing balb/c mice. I. Enhancement of in vivo rejection responses by combined chemotherapy-immunotherapy.
Document Type
Article
Publication Date
1982
Keywords
Chemotherapy:, Immunotherapy:, Neoplasm:, Serology: Antigen,, Types of Tumors:, Transplantable Tumors: MOPC (ALL), Strains: BALB/C
Original Citation
J Nat Cancer Inst 1982; 68:963-9.
COinS